Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion

Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for... Read More
The post Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion appeared first on citybiz.
